AC Immune (ACIU) EBT Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 292,967.00 |
| Dec 31, 2025 | -256,355.00 |
| Sep 30, 2025 | -6,638.00 |
| Jun 30, 2025 | 29,969.00 |
| Mar 31, 2025 | -53,303.00 |
| Dec 31, 2024 | -141,069.00 |
| Sep 30, 2024 | 333,455.00 |
| Dec 31, 2020 | -37,432.00 |
| Sep 30, 2020 | -23,818.00 |
| Jun 30, 2020 | -139,058.00 |
| Mar 31, 2020 | 219,855.00 |
| Dec 31, 2019 | -308,903.00 |
| Sep 30, 2019 | 194,626.00 |
| Jun 30, 2019 | -120,312.00 |
| Mar 31, 2019 | 139,408.00 |
| Dec 31, 2018 | -72,299.00 |
| Sep 30, 2018 | -3,692.00 |
| Jun 30, 2018 | 24,711.00 |
| Mar 31, 2018 | -82,631.00 |
| Dec 31, 2017 | 90,904.00 |
| Sep 30, 2017 | 66,157.00 |
| Jun 30, 2017 | -106,954.00 |
| Mar 31, 2017 | -15,647.00 |
| Dec 31, 2016 | 38,529.00 |
| Mar 31, 2016 | -42,700.00 |
| Dec 31, 2015 | -92,342.00 |